These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22262909)

  • 1. Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease.
    Lim MA; Selak MA; Xiang Z; Krainc D; Neve RL; Kraemer BC; Watts JL; Kalb RG
    J Neurosci; 2012 Jan; 32(3):1123-41. PubMed ID: 22262909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.
    Perera ND; Sheean RK; Scott JW; Kemp BE; Horne MK; Turner BJ
    PLoS One; 2014; 9(3):e90449. PubMed ID: 24595038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of RAD-23 Protects Against Models of Motor Neuron Disease by Enhancing Mutant Protein Clearance.
    Jablonski AM; Lamitina T; Liachko NF; Sabatella M; Lu J; Zhang L; Ostrow LW; Gupta P; Wu CY; Doshi S; Mojsilovic-Petrovic J; Lans H; Wang J; Kraemer B; Kalb RG
    J Neurosci; 2015 Oct; 35(42):14286-306. PubMed ID: 26490867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Almer G; Vukosavic S; Romero N; Przedborski S
    J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.
    Coughlan KS; Mitchem MR; Hogg MC; Prehn JH
    Neurobiol Aging; 2015 Feb; 36(2):1140-50. PubMed ID: 25443289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice.
    Chen K; Northington FJ; Martin LJ
    Brain Struct Funct; 2010 Mar; 214(2-3):219-34. PubMed ID: 19888600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
    Han Y; Ripley B; Serada S; Naka T; Fujimoto M
    PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification.
    Watanabe Y; Yasui K; Nakano T; Doi K; Fukada Y; Kitayama M; Ishimoto M; Kurihara S; Kawashima M; Fukuda H; Adachi Y; Inoue T; Nakashima K
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):12-20. PubMed ID: 15857664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arctigenin derivative A-1 ameliorates motor dysfunction and pathological manifestations in SOD1
    Xiong B; Yang C; Yang X; Luo S; Li S; Chen C; He K; Nie L; Li P; Li S; Huang H; Liu J; Zhang Z; Xie Y; Zou L; Yang X
    CNS Neurosci Ther; 2024 Jun; 30(6):e14692. PubMed ID: 38872258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
    Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death.
    Li B; Xu W; Luo C; Gozal D; Liu R
    Brain Res Mol Brain Res; 2003 Mar; 111(1-2):155-64. PubMed ID: 12654515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation.
    Ström AL; Shi P; Zhang F; Gal J; Kilty R; Hayward LJ; Zhu H
    J Biol Chem; 2008 Aug; 283(33):22795-805. PubMed ID: 18515363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human superoxide dismutase 1 overexpression in motor neurons of Caenorhabditis elegans causes axon guidance defect and neurodegeneration.
    Li J; Li T; Zhang X; Tang Y; Yang J; Le W
    Neurobiol Aging; 2014 Apr; 35(4):837-46. PubMed ID: 24126158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Cytohesins Protects against Genetic Models of Motor Neuron Disease.
    Zhai J; Zhang L; Mojsilovic-Petrovic J; Jian X; Thomas J; Homma K; Schmitz A; Famulok M; Ichijo H; Argon Y; Randazzo PA; Kalb RG
    J Neurosci; 2015 Jun; 35(24):9088-105. PubMed ID: 26085633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking.
    Laird FM; Farah MH; Ackerley S; Hoke A; Maragakis N; Rothstein JD; Griffin J; Price DL; Martin LJ; Wong PC
    J Neurosci; 2008 Feb; 28(9):1997-2005. PubMed ID: 18305234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
    Zhao Z; Sui Y; Gao W; Cai B; Fan D
    J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site.
    Wang J; Xu G; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
    Neurobiol Dis; 2002 Jul; 10(2):128-38. PubMed ID: 12127151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1 G86R.
    Audet JN; Gowing G; Julien JP
    Neurobiol Dis; 2010 Oct; 40(1):245-50. PubMed ID: 20573565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α.
    Song W; Song Y; Kincaid B; Bossy B; Bossy-Wetzel E
    Neurobiol Dis; 2013 Mar; 51():72-81. PubMed ID: 22819776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.